CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (USD $)	Convertible Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Employee Advances	Accumulated Deficit	Total
Beginning Balance, Amount at Dec. 31, 2012	$ 395	$ 13,031	$ 16,460,385	$ (18,858)	$ (20,828,674)	$ (7,793,436)
Beginning Balance, Shares at Dec. 31, 2012	394,685	13,030,397
Stock-based compensation			476,096			476,096
Warrants issued to 2012 private placement investors			487,200			487,200
Issuance of Series B preferred stock as payment-in-kind for dividend, Amount	27		261,057			261,084
Issuance of Series B preferred stock as payment-in-kind for dividend, Shares	27,630
Cashless exercise of warrants into common stock, Amount		10,342	(10,342)
Cashless exercise of warrants into common stock, Shares		10,342,931
Contractual dividends on Series B convertible preferred stock					(209,520)	(209,520)
Beneficial conversion feature and deemed dividend on Series B convertible preferred stock			1,532,722		(1,532,722)
Warrants issued as debt discount in connection with notes payable			315,300			315,300
Conversion of notes and accounts payable into common stock and warrants, Amount		833	3,625,067			3,625,900
Conversion of notes and accounts payable into common stock and warrants, Shares		833,000
Issuance of common stock and warrants for cash, Amount		3,502	3,498,473			3,501,975
Issuance of common stock and warrants for cash, Shares		3,501,975
Imputed value of services contributed			262,500			262,500
Change in fair value of collateral securing employee advances				(13,268)		(13,268)
Net loss					(5,368,482)	(5,368,482)
Ending Balance, Amount at Sep. 30, 2013	$ 422	$ 27,708	$ 26,908,458	$ (32,126)	$ (27,939,398)	$ (4,454,651)
Ending Balance, Shares at Sep. 30, 2013	422,315	27,708,303